EU agreed 15.50 euros a dose for Pfizer vaccine


The cost, which is confidential & was negotiated for a total of 300 million doses, is slightly lower than the $19.50 a photo the United States agreed to purchase a very first shipment of hundred million doses of the same vaccine, in line with what Reuters reported in November.

The EU file dated Nov. 18 was circulated internally after the EU announced the supply package of its with Pfizer and the German partner BioNTech of its on Nov. eleven.

The EU drug regulator is actually expected to decide on Monday on approval for the Pfizer vaccine following the photo was authorised in a few countries, including Britain and also the United States.

On Thursday Belgian say secretary for the spending budget Eva De Bleeker published on Twitter a dining room table with costs Belgium would shell out pharmaceutical companies for their COVID-19 vaccines. She retracted the article shortly after publishing.

In this dining room table the Pfizer vaccine was suggested as costing Belgium twelve euros ($14.6) per dose, top many to believe this was the full cost agreed by the EU.

Other vaccines in the family table were furthermore shown with prices lower compared to rates disclosed by EU sources.

“There is for sure a complete fee along with a price upon delivery,” an EU official required in talks with vaccine creators told Reuters when made to clarify the difference between the Belgian and EU prices.

A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament last week. In that public hearing, De Beeker said Belgium’s budgeted prices were still partial.

Under EU advanced purchase deals for COVID 19 vaccines, the bloc concurs initial payments with companies to secure doses before they’re approved. Following approvals, EU governments can pay the remainder to purchase reserved doses.

The EU has not revealed the initial payment agreed with Pfizer.

But, it said in October that it paid aproximatelly 1 billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for the shots of theirs, with a further 1.45 billion euros budgeted for upfront payments to Pfizer-BioNTech, Moderna and Curevac.

It has since agreed supply deals with all 6 companies and is negotiating a seventh agreement with Novavax.

Leave a Reply

Your email address will not be published. Required fields are marked *